Connect Biopharma (CNTB) Short Interest Ratio & Short Volume $0.98 -0.08 (-7.92%) (As of 05:26 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Connect Biopharma Short Interest DataConnect Biopharma (CNTB) has a short interest of 57,200 shares, representing 0.11% of the float (the number of shares available for trading by the public). This marks a -7.44% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.2, indicating that it would take 2.2 days of the average trading volume of 76,967 shares to cover all short positions.Current Short Interest57,200 sharesPrevious Short Interest61,800 sharesChange Vs. Previous Month-7.44%Dollar Volume Sold Short$60,632.00Short Interest Ratio2.2 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares55,254,000 sharesFloat Size53,250,000 sharesShort Percent of Float0.11%Today's Trading Volume42,727 sharesAverage Trading Volume76,967 sharesToday's Volume Vs. Average56% Short Selling Connect Biopharma? Sign up to receive the latest short interest report for Connect Biopharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCNTB Short Interest Over TimeCNTB Days to Cover Over TimeCNTB Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life-changing for those who are prepared. Why? Because altcoin prices are about to explode.>> Register for the Workshop Now Connect Biopharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/202457,200 shares $60,632.00 -7.4%0.1%2.2 $1.06 11/15/202461,800 shares $68,598.00 +110.2%0.1%2.1 $1.11 10/31/202429,400 shares $34,104.00 -35.4%0.1%1 $1.16 10/15/202445,500 shares $57,330.00 +26.7%0.1%1.7 $1.26 9/30/202435,900 shares $50,978.00 +60.3%0.1%1.2 $1.42 9/15/202422,400 shares $27,552.00 +5.2%0.0%0.5 $1.23 Get the Latest News and Ratings for CNTB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Connect Biopharma and its competitors with MarketBeat's FREE daily newsletter. 8/31/202421,300 shares $34,080.00 +76.0%0.0%0.4 $1.60 8/15/202412,100 shares $13,794.00 -9.7%0.0%0.2 $1.14 7/31/202413,400 shares $15,946.00 +24.1%0.0%0.2 $1.19 7/15/202410,800 shares $13,608.00 -30.3%0.0%0.2 $1.26 6/30/202415,500 shares $23,560.00 -44.2%0.0%0.2 $1.52 6/15/202427,800 shares $44,480.00 -21.5%0.1%0.2 $1.60 5/31/202435,400 shares $60,534.00 -34.6%0.1%0.3 $1.71 5/15/202454,100 shares $99,003.00 +73.4%0.1%0.3 $1.83 4/30/202431,200 shares $43,368.00 -62.5%0.1%0.2 $1.39 4/15/202483,100 shares $138,777.00 -28.1%0.2%0.5 $1.67 3/31/2024115,500 shares $200,970.00 +7.5%0.2%0.7 $1.74 3/15/2024107,400 shares $139,620.00 -13.2%0.2%0.8 $1.30 2/29/2024123,700 shares $141,018.00 -2.7%0.2%0.4 $1.14 2/15/2024127,100 shares $153,791.00 -34.8%0.2%0.4 $1.21 1/31/2024194,800 shares $227,916.00 +52.8%0.4%0.5 $1.17 1/15/2024127,500 shares $140,862.00 -21.3%0.2%0.3 $1.10 12/31/2023162,100 shares $191,278.00 -59.8%0.3%0.4 $1.18 12/15/2023403,200 shares $380,540.16 +208.3%0.8%1.1 $0.94 11/30/2023130,800 shares $150,420.00 +476.2%0.3%0.6 $1.15 11/15/202322,700 shares $40,406.00 -22.8%0.0%0.1 $1.78 10/31/202329,400 shares $43,218.00 +88.5%0.1%0.5 $1.47 10/15/202315,600 shares $13,543.92 -40.7%0.0%0.3 $0.87 9/30/202326,300 shares $21,539.70 +250.7%0.1%0.6 $0.82 9/15/20237,500 shares $5,700.75 -13.8%0.0%0.2 $0.76 8/31/20238,700 shares $7,184.46 -61.5%0.0%0.2 $0.83 8/15/202322,600 shares $20,358.08 -48.3%0.0%0.1 $0.90 7/31/202343,700 shares $42,389.00 +55.5%0.1%0.1 $0.97 7/15/202328,100 shares $30,348.00 -52.5%0.1%0.1 $1.08 6/30/202359,200 shares $66,896.00 -19.8%0.1%0.2 $1.13 6/15/202373,800 shares $74,538.00 -12.3%0.1%0.2 $1.01 5/31/202384,100 shares $91,147.58 +14.3%0.2%0.1 $1.08 5/15/202373,600 shares $91,256.64 -23.1%0.1%0.2 $1.24 4/30/202395,700 shares $101,920.50 -25.8%0.2%0.3 $1.07 4/15/2023128,900 shares $135,345.00 -14.1%0.2%0.4 $1.05Uncover the Top Gold Stock of the Bull Market (Ad)Gold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Click here to see how this opportunity could transform your portfolio. 3/31/2023150,000 shares $149,985.00 +100.8%0.3%0.5 $1.00 3/15/202374,700 shares $83,664.00 -12.2%0.1%0.2 $1.12 2/28/202385,100 shares $109,779.00 -15.0%0.2%1.6 $1.29 2/15/2023100,100 shares $103,103.00 -11.0%0.2%2 $1.03 1/31/2023112,500 shares $138,375.00 -3.5%0.2%2.3 $1.23 1/15/2023116,600 shares $115,317.40 -12.5%0.2%2.3 $0.99 12/30/2022133,200 shares $115,590.96 -58.0%0.3%2.4 $0.87 12/15/2022316,800 shares $275,616.00 -1.2%0.6%2.8 $0.87 11/30/2022320,600 shares $232,531.18 -4.0%0.6%2.8 $0.73 11/15/2022334,000 shares $251,201.40 -8.2%0.6%2.5 $0.75 10/31/2022364,000 shares $316,607.20 -32.0%0.7%2.1 $0.87 10/15/2022535,000 shares $506,003.00 +29.9%1.0%1.7 $0.95 9/30/2022411,900 shares $531,351.00 +2.6%0.8%1.3 $1.29 9/15/2022401,400 shares $586,044.00 -15.7%0.8%1.1 $1.46 8/31/2022476,400 shares $666,960.00 -2.2%0.9%1.2 $1.40 8/15/2022487,100 shares $706,295.00 +1.1%0.9%1.2 $1.45 7/31/2022481,600 shares $392,600.32 +7.6%0.9%1.1 $0.82 7/15/2022447,600 shares $407,316.00 +124.8%0.8%1.1 $0.91 6/30/2022199,100 shares $173,217.00 +7.4%0.4%0.5 $0.87 6/15/2022185,400 shares $133,988.58 -18.0%0.4%0.7 $0.72 5/31/2022226,000 shares $180,800.00 +23.4%N/A0.9 $0.80 5/15/2022183,100 shares $137,325.00 -42.5%N/A0.7 $0.75 4/30/2022318,400 shares $646,352.00 +5.5%N/A1.7 $2.03 4/15/2022301,900 shares $863,434.00 +6.0%N/A3.5 $2.86 3/31/2022284,900 shares $860,398.00 +8.6%N/A2.3 $3.02 3/15/2022262,400 shares $645,504.00 +2.3%N/A1.1 $2.46 2/28/2022256,500 shares $1.01 million +7.1%N/A0.9 $3.92 2/15/2022239,600 shares $1.08 million -24.3%N/A0.7 $4.50 1/31/2022316,600 shares $1.46 million -7.5%0.6%0.7 $4.60 1/15/2022342,400 shares $1.76 million +25.7%N/A0.7 $5.14 12/31/2021272,400 shares $1.40 million +3.6%N/A0.6 $5.15 12/15/2021263,000 shares $1.22 million +533.7%N/A0.8 $4.64 11/30/202141,500 shares $180,525.00 -97.7%N/A0.1 $4.35 11/15/20211,810,000 shares $23.57 million +30.2%N/A7.4 $13.02 10/29/20211,390,000 shares $22.02 million +36.3%N/A15.3 $15.84 10/15/20211,020,000 shares $17.51 million +19.3%N/A13.9 $17.17 9/30/2021855,200 shares $20.72 million +0.1%N/A15.6 $24.23 9/15/2021854,600 shares $18.23 million +0.3%N/A14.2 $21.33 8/31/2021851,700 shares $19.99 million +0.6%N/A13.6 $23.47 8/13/2021846,300 shares $19.90 million No ChangeN/A14.1 $23.51 CNTB Short Interest - Frequently Asked Questions What is Connect Biopharma's current short interest? Short interest is the volume of Connect Biopharma shares that have been sold short but have not yet been closed out or covered. As of November 30th, traders have sold 57,200 shares of CNTB short. 0.11% of Connect Biopharma's shares are currently sold short. Learn More on Connect Biopharma's current short interest. What is a good short interest ratio for Connect Biopharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CNTB shares currently have a short interest ratio of 2.0. Learn More on Connect Biopharma's short interest ratio. What is a good short interest percentage for Connect Biopharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.11% of Connect Biopharma's floating shares are currently sold short. Is Connect Biopharma's short interest increasing or decreasing? Connect Biopharma saw a drop in short interest in the month of November. As of November 30th, there was short interest totaling 57,200 shares, a drop of 7.4% from the previous total of 61,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Connect Biopharma's float size? Connect Biopharma currently has issued a total of 55,254,000 shares. Some of Connect Biopharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Connect Biopharma currently has a public float of 53,250,000 shares. How does Connect Biopharma's short interest compare to its competitors? 0.11% of Connect Biopharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Connect Biopharma: Fulcrum Therapeutics, Inc. (8.49%), Aurora Cannabis Inc. (8.05%), Lexeo Therapeutics, Inc. (9.24%), Tenaya Therapeutics, Inc. (21.42%), Fate Therapeutics, Inc. (9.97%), DiaMedica Therapeutics Inc. (0.35%), Atai Life Sciences (8.71%), Zentalis Pharmaceuticals, Inc. (6.55%), Acrivon Therapeutics, Inc. (5.07%), Molecular Partners AG (0.15%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Connect Biopharma stock? Short selling CNTB is an investing strategy that aims to generate trading profit from Connect Biopharma as its price is falling. CNTB shares are trading down $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Connect Biopharma? A short squeeze for Connect Biopharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CNTB, which in turn drives the price of the stock up even further. How often is Connect Biopharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CNTB, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies FULC Short Interest ACB Short Interest LXEO Short Interest TNYA Short Interest FATE Short Interest DMAC Short Interest ATAI Short Interest ZNTL Short Interest ACRV Short Interest MOLN Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CNTB) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Connect Biopharma Holdings Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Connect Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CNTB Stock Alerts